Trastuzumab deruxtecan (DS-8201a, T-DXd) | ADC | Read Reviews & Product Use Citations

Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. Trastuzumab deruxtecan has a molecular weight of 153KDa. This product is supplied as 10mg/ml PBS solution.

CAS No. 1826843-81-5

Purity & Quality Control

Batch: Purity: 99.86% Protein concentration: 10mg/ml Endotoxin Level: ＜1EU/mg

99.86

Choose Selective ADC Inhibitors

Biological Activity

Description	Trastuzumab deruxtecan (DS-8201a, T-DXd) is an antibody-drug conjugate (ADC) composed of an anti-HER2 (human epidermal growth factor receptor 2) antibody and a cytotoxic topoisomerase I inhibitor. Trastuzumab deruxtecan shows durable antitumor activity. Trastuzumab deruxtecan has a molecular weight of 153KDa. This product is supplied as 10mg/ml PBS solution.

Product Details

CAS No.	1826843-81-5
Molecular Weight	153000
DAR	7.8
ADC antiody	Trastuzumab
ADC cytotoxin	DXd
Formulation	10mg/mL in PBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field